Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Algorithm Monitors Vital Signs and Lab Results to Detect Sepsis before Symptom Onset

By HospiMedica International staff writers
Posted on 25 Jan 2024

Sepsis, a serious blood infection, can initiate a life-threatening chain reaction throughout the body and poses a significant global health challenge. More...

As a dysregulated host response to infection, sepsis affects over 48.9 million people annually worldwide, resulting in approximately 11 million deaths. Early detection of sepsis is crucial for effective treatment, including fluid resuscitation, antibiotic administration, and source control. However, identifying sepsis can be difficult due to its heterogeneous nature. Algorithms designed to aid early sepsis recognition could potentially enhance patient outcomes, yet there is limited research on their real-world impact.

At UC San Diego Health (San Diego, CA, USA), researchers have developed an AI model named COMPOSER to rapidly identify patients at risk of sepsis. This model leverages real-time data to predict sepsis before clear clinical signs emerge. Operating discreetly, COMPOSER continually monitors each patient from the moment they enter the emergency department, analyzing over 150 variables linked to sepsis, including lab results, vital signs, medications, demographics, and medical history. The advanced AI algorithms in COMPOSER can detect subtle patterns not immediately apparent to clinicians. By evaluating these risk factors, the system generates highly accurate sepsis predictions.

Should a patient exhibit a combination of high-risk factors for sepsis, COMPOSER alerts the nursing staff through the hospital’s electronic health record. The nurses then collaborate with physicians to decide the best course of action. If the algorithm determines that the risk patterns are more likely attributed to other conditions, it does not send an alert. Since its activation in December 2022, COMPOSER has been implemented in various in-patient units at UC San Diego Health. A study involving over 6,000 patient admissions before and after deploying COMPOSER in UC San Diego Medical Center and Jacobs Medical Center emergency departments revealed a 17% reduction in mortality, marking the first reported instance of improved patient outcomes through an AI deep-learning model.

“It is because of this AI model that our teams can provide life-saving therapy for patients quicker,” said study co-author Gabriel Wardi, MD, chief of the Division of Critical Care in the Department of Emergency Medicine at UC San Diego School of Medicine.

Related Links:
UC San Diego Health


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.